GYNSTBOSCH: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GYNSTBOSCH
Largest movements
- Cash -€9,180
down €9,180 (-68.9%), from €13,330 to €4,150
mainly Net result for the year (-€9,757) and Deferred charges and accrued income (-€1,019)
- Deferred charges and accrued income +€1,019
up €1,019 (+19.7%), from €5,171 to €6,190
- Receivables within one year +€761
up €761 (+2.2%), from €35,343 to €36,104
of which Other amounts receivable: +€992
- Profit (loss) carried forward -€9,757
down €9,757 (-0.8%), from -€1.2m to -€1.2m
- Trade debts +€2,356
new in 2025: €2,356
- Gross operating margin -€3,029
down €3,029 (-38.4%), from -€7,877 to -€10,906
- Financial income -€183
down €183 (-8.4%), from €2,195 to €2,011
- Other operating charges +€181
up €181 (+34.3%), from €528 to €709
- Financial charges -€151
down €151 (-49.7%), from €305 to €153
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €53,845 | €46,444 | -€7,400 | -13.7% |
| Current assets | 29/58 | €53,845 | €46,444 | -€7,400 | -13.7% |
| Amounts receivable within one year | 40/41 | €35,343 | €36,104 | +€761 | +2.2% |
| Trade receivables | 40 | €231 | - | -€231 | |
| Other amounts receivable | 41 | €35,112 | €36,104 | +€992 | +2.8% |
| Cash at bank and in hand | 54/58 | €13,330 | €4,150 | -€9,180 | -68.9% |
| Deferred charges and accrued income | 490/1 | €5,171 | €6,190 | +€1,019 | +19.7% |
| Total equity and liabilities | 10/49 | €53,845 | €46,444 | -€7,400 | -13.7% |
| Equity | 10/15 | €53,845 | €44,088 | -€9,757 | -18.1% |
| Contributions | 10/11 | €1,242,914 | €1,242,914 | = | 0.0% |
| Capital | 10 | €1,241,849 | €1,241,849 | = | 0.0% |
| Issued capital | 100 | €1,241,849 | €1,241,849 | = | 0.0% |
| Outside capital | 11 | €1,065 | €1,065 | = | 0.0% |
| Share premium | 1100/10 | €1,065 | €1,065 | = | 0.0% |
| Reserves | 13 | €24,405 | €24,405 | = | 0.0% |
| Non-distributable reserves | 130/1 | €24,405 | €24,405 | = | 0.0% |
| Legal reserve | 130 | €24,405 | €24,405 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€1,213,474 | -€1,223,231 | -€9,757 | -0.8% |
| Amounts payable | 17/49 | - | €2,356 | +€2,356 | |
| Amounts payable within one year | 42/48 | - | €2,356 | +€2,356 | |
| Trade debts | 44 | - | €2,356 | +€2,356 | |
| Suppliers | 440/4 | - | €2,356 | +€2,356 | |
| Non-recurring operating income | 76A | €1 | - | -€1 | |
| Other operating charges | 640/8 | €528 | €709 | +€181 | +34.3% |
| Gross operating margin | 9900 | -€7,877 | -€10,906 | -€3,029 | -38.4% |
| Operating profit (loss) | 9901 | -€8,405 | -€11,614 | -€3,210 | -38.2% |
| Financial income | 75/76B | €2,195 | €2,011 | -€183 | -8.4% |
| Recurring financial income | 75 | €2,195 | €2,011 | -€183 | -8.4% |
| Financial charges | 65/66B | €305 | €153 | -€151 | -49.7% |
| Recurring financial charges | 65 | €305 | €153 | -€151 | -49.7% |
| Profit (loss) for the period before taxes | 9903 | -€6,515 | -€9,757 | -€3,242 | -49.8% |
| Profit (loss) for the period | 9904 | -€6,515 | -€9,757 | -€3,242 | -49.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€6,515 | -€9,757 | -€3,242 | -49.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.